kannst ja selber in Filings schauen ob das so ist oder nicht ;-)...
und dann dementsprechend handeln oder auch nicht....
bin aber auch nicht hier drin...
Werbung
| Strategie | Hebel | |||
| Steigender DAX-Kurs | 5,00 | 9,98 | 15,00 | |
| Fallender DAX-Kurs | 5,01 | 10,08 | 15,01 | |
|
könnte eventuell zusätzlich der Grund für den Anstieg sein,
Dr. Errol De Souza, president and chief executive officer of Biodel, stated: "We are very pleased with the results of this study which demonstrate clear-cut superiority of the GEM device with regard to ease-of-use, overall performance and reduction in dosing errors in comparison with the currently marketed glucagon kits. We will use the experience gained from this formative human factors study as a final verification of the device performance, Instructions for Use and instructional labeling before commencing with the summative pivotal human factors study, which we expect to complete by the end of 2015. We remain on track to request an end-of-Phase 2 meeting with the FDA in the second calendar quarter of 2015 and submit the NDA in mid-2016."
investor.biodel.com/releasedetail.cfm?releaseid=904936
|
Werbung
| Strategie | Hebel | |||
| Steigender DAX-Kurs | 5,00 | 9,98 | 15,00 | |
| Fallender DAX-Kurs | 5,01 | 10,08 | 15,01 | |
| Wertung | Antworten | Thema | Verfasser | letzter Verfasser | letzter Beitrag | |
| 15 | 8.845 | Albireo neuer big player im Pharma-Milliardenmarkt | RoStock | Glatzenkogel | 23.12.23 11:22 | |
| 14 | 5.574 | Biodel - Marlboro für das Depot? | Temesta | Temesta | 09.01.23 18:25 | |
| 15 | 7.608 | ALBO Polarstern Vorraus! Für Longies und Fakten! | 1SOJ | Glatzenkogel | 09.06.22 11:14 | |
| 2 | 72 | am 30.10.2010 entscheidet hier die FDA | Lapismuc | derbestezocker | 25.04.21 01:31 | |
| 3 | 110 | Albireo Pharma DL -,01 | newbie_evo | Uhrzeit | 25.04.21 00:48 |